An unusual form of autoimmune hepatitis in young Somalian men

Liver International

Volumn 25, Issue 2, 2005, Pages 325-330

  D'Souza, R ^a   Sinnott, P ^b   Glynn, M J ^a   Sabin, C A ^b   Foster, G R ^a,c  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^c ROYAL LONDON HOSPITAL   (United Kingdom)

Author keywords

Autoimmune hepatitis; Immuno suppressive therapy; Somalian men

Indexed keywords

AZATHIOPRINE; HLA ANTIGEN; IMMUNOSUPPRESSIVE AGENT; PREDNISOLONE; STEROID;

ADULT; AUTOIMMUNE HEPATITIS; CHOLESTASIS; CLINICAL ARTICLE; CLINICAL FEATURE; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; EUROPE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOLOGY; IMMUNOSUPPRESSIVE TREATMENT; MALE; RETROSPECTIVE STUDY; REVIEW; SOMALIA; STATISTICAL SIGNIFICANCE;

ADULT; AFRICAN AMERICANS; AGE DISTRIBUTION; COHORT STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; GREAT BRITAIN; HEPATITIS, AUTOIMMUNE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PROBABILITY; PROGNOSIS; REGISTRIES; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SOMALIA; STATISTICS, NONPARAMETRIC;

EID: 17044393582     PISSN: 14783223     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2005.01088.x     Document Type: Review

References (24)

1. Czaja A J, Freese D K. American association for the study of liver diagnosis and treatment of autoimmune hepatitis. Hepatology 2002; 36: 479-97.
2. Czaja A J. Autoimmune hepatitis: evolving concepts and strategies. Dig Dis Sci 1995; 40: 435-6.
3. International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 1999; 31: 929-38.
4. Johnson P, McFarlane I. Meeting report: international autoimmune hepatitis group. Hepatology 1993; 18: 998-1005.
5. MacKay I R, Morris P. Association of autoimmune chronic hepatitis with HLA-A1-B8. Lancet 1972; 2: 793-5.
6. Donaldson P, Doherty D, Hayllar K, et al. Susceptibilty to autoimmune chronic active hepatitis: human leukocyte antigens DR4 and A1-B8-DR3 are independent risk factors. Hepatology 1991; 13: 701-6.
7. Kilby A E, Albertini R, Krawitt E. HLA typing and autoantibodies in hepatitis B surface antigen negative chronic active hepatitis. Tissue Antigens 1986; 28: 214-7.
8. Seki S, Kiyosawa K, Ota M. Association of autoimmune hepatitis with HLA-Bw4 and DR4 in Japanese patients. Hepatology 1990; 12: 1300-4.
9. Czaja A, Manns M, MacFarlane I, et al. Autoimmune hepatitis: the investigational and clinical challenges. Hepatology 2000; 31: 1194-200.
10. Zolfino T, Heneghan M, Norris S, et al. Characteristics of autoimmune hepatitis in patients who are not of European Caucasoid ethnic origin. Gut 2002; 50: 713-7.
11. Ishak K, Bapista A, Bianchi L, et al. Histological grading and staging of chronic hepatitis. J Hepatol 1995; 22: 696-9.
12. Johnson P, McFarlane I, Williams R. Azathioprine for long-term maintenance of remission in autoimmune hepatitis. N Engl J Med 1995; 333: 958-63.
13. Abdo A, Bain V, Kichian K, et al. Evolution of autoimmune hepatitis to primary sclerosing cholangitis: a sequential syndrome. Hepatology 2002; 36: 1393-9.
14. Lohse A, Meyer zum Buschenfelde K, Franz B, et al. Characterisation of the overlap syndrome of primary biliary cirrhosis (PBC) and autoimmune hepatitis: evidence for it being a hepatitic form of PBC in genetically susceptible individuals. Hepatology 1999; 29: 1078-84.
15. Molina J F, Molina J, Garcia C, et al. Ethnic differences in the clinical expression of systemic lupus erythematosus: a comparative study between African-Americans and Latin Americans. Lupus 1997; 6: 63-7.
16. Arfken C, Reno P, Santiago J, et al. Development of proliferative diabetic retinopathy in African-Americans and whites with type 1 diabetes. Diabetes Care 1998; 21: 792-5.
17. Ward M, Lazda V, Gaddis P, et al. In vitro response to immunosuppressive agents in blacks. Transplant Proc 1993; 25: 2470-1.
18. McLeod H, Lin J, Scott E, et al. Thiopurine methyltransferase activity in American white subjects and black subjects. Clin Pharmacol Ther 1994; 55: 15-20.
19. Chocair P, Duley J, Sabbaga E, et al. Fast and slow methylators: do racial differences influence risk of allograft rejection. QJM 1993; 83: 359-63.
20. Czaja A, Strettell M, Thomson L, et al. Associations between alleles of the major histocompatibilty complex and type 1 autoimmune hepatitis. Hepatology 1997; 25: 317-23.
21. Griffiths B, Situnayake R, Clark B, et al. Racial origin and its effect on disease expression and HLA-DRB1 types in patients with rheumatoid arthritis: a matched cross-sectional study. Rheumatology 2000; 39: 857-64.
22. Pando M, Larriba J, Fernandez G, et al. Paediatric and adult forms of type1 autoimmune hepatitis in Argentina: evidence for differential genetic predisposition. Hepatology 1999; 30: 1374-80.
23. Vazquez-Garcia M, Alaez C, Olivo A, et al. MHC class II sequences of susceptibility and protection in Mexicans with autoimmune hepatitis. J Heptol 1998; 28: 985-90.
24. Bittncourt P, Goldberg, A, Cancado E, et al. Genetic heterogeneity in susceptibility to autoimmune hepatitis types 1 and 2. Am J Gastroenterol 1999; 94: 1906-16.